{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T10:47:17Z","timestamp":1776509237190,"version":"3.51.2"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00417-026-07128-0","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:17:58Z","timestamp":1771654678000},"page":"1189-1200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The CAPA framework: a conceptual model integrating corrective and preventive strategies for retinal ischemia and neovascularization"],"prefix":"10.1007","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4479-9390","authenticated-orcid":false,"given":"Ramesh","family":"Venkatesh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishma","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratibha","family":"Hande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaitra","family":"Jayadev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupak","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soema","family":"Tebhla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pragati","family":"Raj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhav","family":"Pai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karishma","family":"Tendulkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Chhablani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,21]]},"reference":[{"key":"7128_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.survophthal.2022.11.007","volume":"68","author":"M Fevereiro-Martins","year":"2023","unstructured":"Fevereiro-Martins M, Marques-Neves C, Guimar\u00e3es H, Bicho M (2023) Retinopathy of prematurity: a review of pathophysiology and signaling pathways. Surv Ophthalmol 68:175\u2013210. https:\/\/doi.org\/10.1016\/j.survophthal.2022.11.007","journal-title":"Surv Ophthalmol"},{"issue":"Suppl 2","key":"7128_CR2","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1186\/ar2193","volume":"9","author":"L Guillevin","year":"2007","unstructured":"Guillevin L, D\u00f6rner T (2007) Vasculitis: mechanisms involved and clinical manifestations. Arthritis Res Ther 9(Suppl 2):S9. https:\/\/doi.org\/10.1186\/ar2193","journal-title":"Arthritis Res Ther"},{"key":"7128_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1046\/j.1365-2990.2003.00499.x","volume":"29","author":"EH Hughes","year":"2003","unstructured":"Hughes EH, Dick AD (2003) The pathology and pathogenesis of retinal vasculitis. Neuropathol Appl Neurobiol 29:325\u2013340. https:\/\/doi.org\/10.1046\/j.1365-2990.2003.00499.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"7128_CR4","doi-asserted-by":"publisher","first-page":"100514","DOI":"10.1016\/j.xops.2024.100514","volume":"4","author":"H Kondo","year":"2024","unstructured":"Kondo H, Tsukahara-Kawamura T, Matsushita I et al (2024) Familial exudative vitreoretinopathy with and without pathogenic variants of Norrin\/\u03b2-catenin signaling genes. Ophthalmol Sci 4:100514. https:\/\/doi.org\/10.1016\/j.xops.2024.100514","journal-title":"Ophthalmol Sci"},{"key":"7128_CR5","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1111\/j.1538-7836.2010.03909.x","volume":"8","author":"M Rehak","year":"2010","unstructured":"Rehak M, Wiedemann P (2010) Retinal vein thrombosis: pathogenesis and management. J Thromb Haemost 8:1886\u20131894. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03909.x","journal-title":"J Thromb Haemost"},{"key":"7128_CR6","doi-asserted-by":"publisher","first-page":"RA138","DOI":"10.12659\/msm.883260","volume":"18","author":"B Terelak-Borys","year":"2012","unstructured":"Terelak-Borys B, Skonieczna K, Grabska-Liberek I (2012) Ocular ischemic syndrome - a systematic review. Med Sci Monit 18:RA138\u2013144. https:\/\/doi.org\/10.12659\/msm.883260","journal-title":"Med Sci Monit"},{"key":"7128_CR7","doi-asserted-by":"publisher","first-page":"963615","DOI":"10.3389\/fcell.2022.963615","volume":"10","author":"L Wei","year":"2022","unstructured":"Wei L, Sun X, Fan C et al (2022) The pathophysiological mechanisms underlying diabetic retinopathy. Front Cell Dev Biol 10:963615. https:\/\/doi.org\/10.3389\/fcell.2022.963615","journal-title":"Front Cell Dev Biol"},{"key":"7128_CR8","doi-asserted-by":"publisher","first-page":"11850","DOI":"10.3390\/ijms252111850","volume":"25","author":"JV Srejovic","year":"2024","unstructured":"Srejovic JV, Muric MD, Jakovljevic VLj et al (2024) Molecular and cellular mechanisms involved in the pathophysiology of retinal vascular disease\u2014interplay between inflammation and oxidative stress. IJMS 25:11850. https:\/\/doi.org\/10.3390\/ijms252111850","journal-title":"IJMS"},{"key":"7128_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.preteyeres.2015.06.002","volume":"49","author":"PA Campochiaro","year":"2015","unstructured":"Campochiaro PA (2015) Molecular pathogenesis of retinal and choroidal vascular diseases. Prog Retin Eye Res 49:67\u201381. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.06.002","journal-title":"Prog Retin Eye Res"},{"key":"7128_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S1050-1738(97)00091-1","volume":"7","author":"Y Dor","year":"1997","unstructured":"Dor Y, Keshet E (1997) Ischemia-driven angiogenesis. Trends Cardiovasc Med 7:289\u2013294. https:\/\/doi.org\/10.1016\/S1050-1738(97)00091-1","journal-title":"Trends Cardiovasc Med"},{"key":"7128_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-025-02249-0","volume":"10","author":"C Lee","year":"2025","unstructured":"Lee C, Kim M-J, Kumar A et al (2025) Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives. Sig Transduct Target Ther 10:170. https:\/\/doi.org\/10.1038\/s41392-025-02249-0","journal-title":"Sig Transduct Target Ther"},{"key":"7128_CR12","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s12272-025-01545-1","volume":"48","author":"FH Shah","year":"2025","unstructured":"Shah FH, Nam YS, Bang JY et al (2025) Targeting vascular endothelial growth receptor-2 (VEGFR-2): structural biology, functional insights, and therapeutic resistance. Arch Pharm Res 48:404\u2013425. https:\/\/doi.org\/10.1007\/s12272-025-01545-1","journal-title":"Arch Pharm Res"},{"key":"7128_CR13","doi-asserted-by":"publisher","first-page":"100954","DOI":"10.1016\/j.preteyeres.2021.100954","volume":"84","author":"A Uemura","year":"2021","unstructured":"Uemura A, Fruttiger M, D\u2019Amore PA et al (2021) VEGFR1 signaling in retinal angiogenesis and microinflammation. Prog Retin Eye Res 84:100954. https:\/\/doi.org\/10.1016\/j.preteyeres.2021.100954","journal-title":"Prog Retin Eye Res"},{"key":"7128_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.preteyeres.2003.12.001","volume":"23","author":"NN Osborne","year":"2004","unstructured":"Osborne NN, Casson RJ, Wood JPM et al (2004) Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 23:91\u2013147. https:\/\/doi.org\/10.1016\/j.preteyeres.2003.12.001","journal-title":"Prog Retin Eye Res"},{"key":"7128_CR15","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/s0161-6420(84)34123-9","volume":"91","author":"BH Doft","year":"1984","unstructured":"Doft BH, Blankenship G (1984) Retinopathy risk factor regression after laser panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 91:1453\u20131457. https:\/\/doi.org\/10.1016\/s0161-6420(84)34123-9","journal-title":"Ophthalmology"},{"key":"7128_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11892-021-01403-6","volume":"21","author":"LA Everett","year":"2021","unstructured":"Everett LA, Paulus YM (2021) Laser therapy in the treatment of diabetic retinopathy and diabetic macular edema. Curr Diab Rep 21:35. https:\/\/doi.org\/10.1007\/s11892-021-01403-6","journal-title":"Curr Diab Rep"},{"key":"7128_CR17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12886-021-01964-w","volume":"21","author":"HE Feng","year":"2021","unstructured":"Feng HE, Weihong YU, Dong F (2021) Observation of retinal neovascularization using optical coherence tomography angiography after panretinal photocoagulation for proliferative diabetic retinopathy. BMC Ophthalmol 21:252. https:\/\/doi.org\/10.1186\/s12886-021-01964-w","journal-title":"BMC Ophthalmol"},{"key":"7128_CR18","doi-asserted-by":"publisher","first-page":"1897344","DOI":"10.1155\/2022\/1897344","volume":"2022","author":"J-W Kwon","year":"2022","unstructured":"Kwon J-W, Oh J (2022) Aqueous humor analyses in patients with diabetic retinopathy who had undergone panretinal photocoagulation. J Diabetes Res 2022:1897344. https:\/\/doi.org\/10.1155\/2022\/1897344","journal-title":"J Diabetes Res"},{"key":"7128_CR19","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1001\/archopht.1979.01020010352013","volume":"97","author":"RP Murphy","year":"1979","unstructured":"Murphy RP, Egbert PR (1979) Regression of iris neovascularization following panretinal photocoagulation. Arch Ophthalmol 97:700\u2013702. https:\/\/doi.org\/10.1001\/archopht.1979.01020010352013","journal-title":"Arch Ophthalmol"},{"key":"7128_CR20","doi-asserted-by":"publisher","unstructured":"(1978) Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings. Ophthalmology 85:82\u2013106. https:\/\/doi.org\/10.1016\/s0161-6420(78)35693-1","DOI":"10.1016\/s0161-6420(78)35693-1"},{"key":"7128_CR21","doi-asserted-by":"crossref","unstructured":"(1981) Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of diabetic retinopathy study (DRS) findings, DRS report number 8. The diabetic retinopathy study research group. Ophthalmology 88:583\u2013600","DOI":"10.1016\/S0161-6420(81)34978-1"},{"key":"7128_CR22","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0161-6420(13)38011-7","volume":"98","author":"Early Treatment Diabetic Retinopathy Study Research Group","year":"1991","unstructured":"Early Treatment Diabetic Retinopathy Study Research Group (1991) Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology 98:766\u2013785","journal-title":"Ophthalmology"},{"key":"7128_CR23","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/S0140-6736(17)31193-5","volume":"389","author":"S Sivaprasad","year":"2017","unstructured":"Sivaprasad S, Prevost AT, Vasconcelos JC et al (2017) Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial. Lancet 389:2193\u20132203. https:\/\/doi.org\/10.1016\/S0140-6736(17)31193-5","journal-title":"Lancet"},{"issue":"20","key":"7128_CR24","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1001\/jama.2015.15217","volume":"314","author":"JG Gross","year":"2015","unstructured":"Gross JG, Glassman AR et al (2015) Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA 314:2137. https:\/\/doi.org\/10.1001\/jama.2015.15217","journal-title":"JAMA"},{"key":"7128_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2025.05.033","author":"RN Khurana","year":"2025","unstructured":"Khurana RN, Wang JC, Zhang S et al (2025) Outcomes of patients with proliferative diabetic retinopathy treated with anti-VEGF therapy and\/or panretinal photocoagulation in the United States who were lost to follow-up. Ophthalmology. https:\/\/doi.org\/10.1016\/j.oret.2025.05.033","journal-title":"Ophthalmology"},{"key":"7128_CR26","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41433-025-03641-4","volume":"39","author":"K Luckham","year":"2025","unstructured":"Luckham K, Tebbs H, Claxton L et al (2025) A Markov model assessing the cost-effectiveness of various anti-vascular endothelial growth factor drugs and panretinal photocoagulation for the treatment of proliferative diabetic retinopathy. Eye Lond 39:1364\u20131372. https:\/\/doi.org\/10.1038\/s41433-025-03641-4","journal-title":"Eye Lond"},{"key":"7128_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.oret.2024.08.004","volume":"9","author":"M-M Macaron","year":"2025","unstructured":"Macaron M-M, Al Sabbakh N, Shami MZ et al (2025) Anti-VEGF injections vs. Panretinal photocoagulation laser therapy for proliferative diabetic retinopathy: A systematic review and Meta-Analysis. Ophthalmol Retina 9:105\u2013121. https:\/\/doi.org\/10.1016\/j.oret.2024.08.004","journal-title":"Ophthalmol Retina"},{"key":"7128_CR28","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1001\/jamaophthalmol.2019.5939","volume":"138","author":"MG Maguire","year":"2020","unstructured":"Maguire MG, Liu D, Glassman AR et al (2020) Visual field changes over 5 years in patients treated with panretinal photocoagulation or ranibizumab for proliferative diabetic retinopathy. JAMA Ophthalmol 138:285\u2013293. https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.5939","journal-title":"JAMA Ophthalmol"},{"key":"7128_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/MJYP6578","volume":"29","author":"M Simmonds","year":"2025","unstructured":"Simmonds M, Llewellyn A, Walker R et al (2025) Anti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy: a systematic review and individual participant data meta-analysis. Health Technol Assess 29:1\u201375. https:\/\/doi.org\/10.3310\/MJYP6578","journal-title":"Health Technol Assess"},{"key":"7128_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/ICU.0000000000000760","volume":"32","author":"MH Berrocal","year":"2021","unstructured":"Berrocal MH, Acaba-Berrocal L (2021) Early pars plana vitrectomy for proliferative diabetic retinopathy: update and review of current literature. Curr Opin Ophthalmol 32:203\u2013208. https:\/\/doi.org\/10.1097\/ICU.0000000000000760","journal-title":"Curr Opin Ophthalmol"},{"key":"7128_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ajo.2024.10.019","volume":"270","author":"R Anguita","year":"2025","unstructured":"Anguita R, Ferro Desideri L, Schwember P et al (2025) Early versus delayed vitrectomy for vitreous hemorrhage secondary to proliferative diabetic retinopathy. Am J Ophthalmol 270:237\u2013244. https:\/\/doi.org\/10.1016\/j.ajo.2024.10.019","journal-title":"Am J Ophthalmol"},{"key":"7128_CR32","doi-asserted-by":"publisher","first-page":"51\u201351","DOI":"10.21037\/aes.2018.09.04","volume":"3","author":"M De Maria","year":"2018","unstructured":"De Maria M, Panchal B, Coassin M (2018) Update on indications for diabetic vitrectomy and management of complications. Ann Eye Sci 3:51\u201351. https:\/\/doi.org\/10.21037\/aes.2018.09.04","journal-title":"Ann Eye Sci"},{"key":"7128_CR33","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1001\/jamaophthalmol.2022.5817","volume":"141","author":"P McCullough","year":"2023","unstructured":"McCullough P, Mohite A, Virgili G, Lois N (2023) Outcomes and complications of pars plana vitrectomy for tractional retinal detachment in people with diabetes: a systematic review and meta-analysis. JAMA Ophthalmol 141:186. https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.5817","journal-title":"JAMA Ophthalmol"},{"key":"7128_CR34","doi-asserted-by":"publisher","first-page":"e0220726","DOI":"10.1371\/journal.pone.0220726","volume":"14","author":"JT Sokol","year":"2019","unstructured":"Sokol JT, Schechet SA, Rosen DT et al (2019) Outcomes of vitrectomy for diabetic tractional retinal detachment in Chicago\u2019s county health system. PLoS One 14:e0220726. https:\/\/doi.org\/10.1371\/journal.pone.0220726","journal-title":"PLoS One"},{"key":"7128_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40662-020-00195-2","volume":"7","author":"OA Sorour","year":"2020","unstructured":"Sorour OA, Mehta N, Baumal CR et al (2020) Morphological changes in intraretinal microvascular abnormalities after anti-VEGF therapy visualized on optical coherence tomography angiography. Eye Vis 7:29. https:\/\/doi.org\/10.1186\/s40662-020-00195-2","journal-title":"Eye Vis"},{"key":"7128_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.exer.2014.10.016","volume":"133","author":"I Klaassen","year":"2015","unstructured":"Klaassen I, van Geest RJ, Kuiper EJ et al (2015) The role of CTGF in diabetic retinopathy. Exp Eye Res 133:37\u201348. https:\/\/doi.org\/10.1016\/j.exer.2014.10.016","journal-title":"Exp Eye Res"},{"key":"7128_CR37","doi-asserted-by":"publisher","first-page":"e2675","DOI":"10.1371\/journal.pone.0002675","volume":"3","author":"EJ Kuiper","year":"2008","unstructured":"Kuiper EJ, Van Nieuwenhoven FA, de Smet MD et al (2008) The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy. PLoS One 3:e2675. https:\/\/doi.org\/10.1371\/journal.pone.0002675","journal-title":"PLoS One"},{"key":"7128_CR38","doi-asserted-by":"publisher","first-page":"8701","DOI":"10.1167\/iovs.11-7870","volume":"52","author":"L Pi","year":"2011","unstructured":"Pi L, Xia H, Liu J et al (2011) Role of connective tissue growth factor in the retinal vasculature during development and ischemia. Invest Ophthalmol Vis Sci 52:8701. https:\/\/doi.org\/10.1167\/iovs.11-7870","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7128_CR39","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/eye.2014.13","volume":"28","author":"P Osaadon","year":"2014","unstructured":"Osaadon P, Fagan XJ, Lifshitz T, Levy J (2014) A review of anti-VEGF agents for proliferative diabetic retinopathy. Eye 28:510\u2013520. https:\/\/doi.org\/10.1038\/eye.2014.13","journal-title":"Eye"},{"key":"7128_CR40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1755-3768.2010.02079.x","volume":"89","author":"A Salam","year":"2011","unstructured":"Salam A, Mathew R, Sivaprasad S (2011) Treatment of proliferative diabetic retinopathy with anti-VEGF agents. Acta Ophthalmol 89:405\u2013411. https:\/\/doi.org\/10.1111\/j.1755-3768.2010.02079.x","journal-title":"Acta Ophthalmol"},{"key":"7128_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/diagnostics14010031","volume":"14","author":"M Gaw\u0119cki","year":"2023","unstructured":"Gaw\u0119cki M, Kici\u0144ski K, Bianco L, Battaglia Parodi M (2023) Regression of neovascularization after panretinal photocoagulation combined with anti-VEGF injection for proliferative diabetic retinopathy\u2014a review. Diagnostics 14:31. https:\/\/doi.org\/10.3390\/diagnostics14010031","journal-title":"Diagnostics"},{"issue":"3","key":"7128_CR42","doi-asserted-by":"publisher","first-page":"CD008721","DOI":"10.1002\/14651858.CD008721.pub3","volume":"2023","author":"MJ Martinez-Zapata","year":"2023","unstructured":"Martinez-Zapata MJ, Salvador I, Mart\u00ed-Carvajal AJ et al (2023) Anti-vascular endothelial growth factor for proliferative diabetic retinopathy. Cochrane Database Syst Rev (3):CD008721. https:\/\/doi.org\/10.1002\/14651858.CD008721.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"7128_CR43","doi-asserted-by":"publisher","first-page":"e73286","DOI":"10.7759\/cureus.73286","volume":"16","author":"M Dablouk","year":"2024","unstructured":"Dablouk M, Chhabra A, Masoud AT (2024) Recurrence of retinopathy of prematurity following anti-vascular endothelial growth factor (Anti-VEGF) therapy: a systematic review and meta-analysis. Cureus 16:e73286. https:\/\/doi.org\/10.7759\/cureus.73286","journal-title":"Cureus"},{"key":"7128_CR44","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1001\/jamaophthalmol.2018.3255","volume":"136","author":"JG Gross","year":"2018","unstructured":"Gross JG, Glassman AR, Liu D et al (2018) Five-year outcomes of panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA Ophthalmol 136:1138\u20131148. https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.3255","journal-title":"JAMA Ophthalmol"},{"key":"7128_CR45","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/aos.14482","volume":"99","author":"V Schreur","year":"2021","unstructured":"Schreur V, Brouwers J, Van Huet RAC et al (2021) Long-term outcomes of vitrectomy for proliferative diabetic retinopathy. Acta Ophthalmol 99:83\u201389. https:\/\/doi.org\/10.1111\/aos.14482","journal-title":"Acta Ophthalmol"},{"key":"7128_CR46","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/eye.2009.325","volume":"24","author":"DK Newman","year":"2010","unstructured":"Newman DK (2010) Surgical management of the late complications of proliferative diabetic retinopathy. Eye 24:441\u2013449. https:\/\/doi.org\/10.1038\/eye.2009.325","journal-title":"Eye"},{"key":"7128_CR47","doi-asserted-by":"publisher","first-page":"519","DOI":"10.4103\/tjo.TJO-D-23-00108","volume":"14","author":"NC Patel","year":"2024","unstructured":"Patel NC, Hsieh Y-T, Yang C-M et al (2024) Vitrectomy for diabetic retinopathy: a review of indications, techniques, outcomes, and complications. Taiwan J Ophthalmol 14:519\u2013530. https:\/\/doi.org\/10.4103\/tjo.TJO-D-23-00108","journal-title":"Taiwan J Ophthalmol"},{"key":"7128_CR48","volume-title":"Handbook of Investigation and Effective CAPA Systems","author":"J Rodriguez-Perez","year":"2025","unstructured":"Rodriguez-Perez J (2025) Handbook of Investigation and Effective CAPA Systems, 3rd Edition. American Society for Quality, Quality Press, Milwaukee 53203","edition":"3rd Edition"},{"key":"7128_CR49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1167\/iovs.61.3.34","volume":"61","author":"A Shimouchi","year":"2020","unstructured":"Shimouchi A, Ishibazawa A, Ishiko S et al (2020) A proposed classification of intraretinal microvascular abnormalities in diabetic retinopathy following panretinal photocoagulation. Invest Ophthalmol Vis Sci 61:34. https:\/\/doi.org\/10.1167\/iovs.61.3.34","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7128_CR50","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/978-1-4614-3646-1_21","volume-title":"Retinal and choroidal manifestations of selected systemic diseases","author":"JF Ar\u00e9valo","year":"2013","unstructured":"Ar\u00e9valo JF, Ar\u00e9valo JF, Lasave AF et al (2013) Diabetic retinopathy. In: Ar\u00e9valo JF (ed) Retinal and choroidal manifestations of selected systemic diseases. Springer New York, New York, NY, pp 387\u2013416"},{"key":"7128_CR51","volume-title":"Diabetic retinopathy","author":"UV Shukla","year":"2025","unstructured":"Shukla UV, Tripathy K (2025) Diabetic retinopathy. In: StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"7128_CR52","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1097\/IAE.0000000000002671","volume":"40","author":"M Arya","year":"2020","unstructured":"Arya M, Sorour O, Chaudhri J et al (2020) Distinguishing intraretinal microvascular abnormalities from retinal neovascularization using optical coherence tomography angiography. Retina 40:1686\u20131695. https:\/\/doi.org\/10.1097\/IAE.0000000000002671","journal-title":"Retina"},{"key":"7128_CR53","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1167\/iovs.65.8.29","volume":"65","author":"X Ding","year":"2024","unstructured":"Ding X, Romano F, Garg I et al (2024) Longitudinal assessment of intraretinal microvascular abnormalities in diabetic retinopathy using swept-source optical coherence tomography angiography. Invest Ophthalmol Vis Sci 65:29. https:\/\/doi.org\/10.1167\/iovs.65.8.29","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7128_CR54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4103\/2347-5617.135244","volume":"1","author":"MA Aboeuhussein","year":"2013","unstructured":"Aboeuhussein MA (2013) Optical coherence tomography evaluation of retinal and optic nerve head neovascularization in proliferative diabetic retinopathy. Egypt Retina J 1:23. https:\/\/doi.org\/10.4103\/2347-5617.135244","journal-title":"Egypt Retina J"},{"key":"7128_CR55","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ajo.2015.10.025","volume":"162","author":"M Adhi","year":"2016","unstructured":"Adhi M, Badaro E, Liu JJ et al (2016) Three dimensional enhanced imaging of vitreoretinal interface in diabetic retinopathy using swept source optical coherence tomography. Am J Ophthalmol 162:140-149.e1. https:\/\/doi.org\/10.1016\/j.ajo.2015.10.025","journal-title":"Am J Ophthalmol"},{"key":"7128_CR56","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.3390\/jcm11123266","volume":"11","author":"A Lin","year":"2022","unstructured":"Lin A, Xia H, Zhang A et al (2022) Vitreomacular interface disorders in proliferative diabetic retinopathy: an optical coherence tomography study. J Clin Med 11:3266. https:\/\/doi.org\/10.3390\/jcm11123266","journal-title":"J Clin Med"},{"key":"7128_CR57","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1038\/s41433-025-03891-2","volume":"39","author":"A-L Wu","year":"2025","unstructured":"Wu A-L, Guo Y, Hormel TT et al (2025) Wide-field OCTA quantified peripheral nonperfusion areas predict the risk of subclinical neovascularization. Eye Lond 39:2467\u20132473. https:\/\/doi.org\/10.1038\/s41433-025-03891-2","journal-title":"Eye Lond"},{"key":"7128_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1521837","author":"C Guo","year":"2025","unstructured":"Guo C, Xiao N, Li F et al (2025) Comparison of widefield swept-source optical coherence tomography angiography and ultra-widefield fluorescein angiography in the detection of non-perfusion areas in diabetic retinopathy. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2025.1521837","journal-title":"Front Endocrinol"},{"key":"7128_CR59","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s12886-023-03073-2","volume":"23","author":"Y Yang","year":"2023","unstructured":"Yang Y, Li F, Liu T et al (2023) Comparison of widefield swept-source optical coherence tomographic angiography and fluorescein fundus angiography for detection of retinal neovascularization with diabetic retinopathy. BMC Ophthalmol 23:315. https:\/\/doi.org\/10.1186\/s12886-023-03073-2","journal-title":"BMC Ophthalmol"},{"key":"7128_CR60","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2147\/OPTH.S182420","volume":"13","author":"FI Shakarchi","year":"2018","unstructured":"Shakarchi FI, Shakarchi AF, Al-Bayati SA (2018) Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab. Clin Ophthalmol 13:27\u201331. https:\/\/doi.org\/10.2147\/OPTH.S182420","journal-title":"Clin Ophthalmol"},{"key":"7128_CR61","doi-asserted-by":"publisher","first-page":"e240506","DOI":"10.1136\/bcr-2020-240506","volume":"14","author":"AJ Bromeo","year":"2021","unstructured":"Bromeo AJ, Veloso A, Lerit SJ, Gomez MC (2021) Tractional retinal detachment (\u2018crunch\u2019 phenomenon) from intravitreal anti-vascular endothelial growth factor injection in central retinal vein occlusion. BMJ Case Rep 14:e240506. https:\/\/doi.org\/10.1136\/bcr-2020-240506","journal-title":"BMJ Case Rep"},{"key":"7128_CR62","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.survophthal.2021.03.001","volume":"66","author":"Y Tan","year":"2021","unstructured":"Tan Y, Fukutomi A, Sun MT et al (2021) Anti-VEGF crunch syndrome in proliferative diabetic retinopathy: a review. Surv Ophthalmol 66:926\u2013932. https:\/\/doi.org\/10.1016\/j.survophthal.2021.03.001","journal-title":"Surv Ophthalmol"},{"key":"7128_CR63","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","volume":"364","author":"HA Mintz-Hittner","year":"2011","unstructured":"Mintz-Hittner HA, Kennedy KA, Chuang AZ (2011) Efficacy of intravitreal bevacizumab for stage 3\u2009+\u2009retinopathy of prematurity. N Engl J Med 364:603\u2013615. https:\/\/doi.org\/10.1056\/NEJMoa1007374","journal-title":"N Engl J Med"},{"key":"7128_CR64","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3126\/nepjoph.v14i2.39516","volume":"14","author":"R Venkatesh","year":"2022","unstructured":"Venkatesh R, Reddy N, Jayadev C et al (2022) Proliferative diabetic retinopathy detection: comparison of clinical examination, optomap photographs and fluorescein angiography. Nepalese J Ophthalmol 14:86\u201396. https:\/\/doi.org\/10.3126\/nepjoph.v14i2.39516","journal-title":"Nepalese J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07128-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07128-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07128-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T10:17:45Z","timestamp":1776507465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07128-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,21]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["7128"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07128-0","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,21]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This article is a review of previously published literature and does not involve any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This manuscript does not include any individual participant data; therefore, consent for publication is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}